To study the effect of Rasotanjan and Kasisanjan in the management of Arjuna

COMPARATIVE CLINICAL STUDY OF EFFICACY OF RASOTANJAN AND KASISANJAN IN THE MANAGEMENT OF ARJUNA WITH SPECIAL REFERENCE TO SUB CONJUNCTIVAL HAEMORRHAGE

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039076

Enrollment

Registered

2022-01-03

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H113- Conjunctival hemorrhage

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: -Patients having Lakshanas of Arjuna Vyadhi -Patients with age group of 18-60 years -Patients having ocular trauma with sub-conjunctival haemorrhage without visual loss -Patients complaining of spontaneous ocular haemorrhage along with history of hypertension, cough, vomiting etc. without visual loss

Exclusion criteria

Exclusion criteria: -Patient having age below 18 years and above 60 years -Recently operated eye -Patients with other ocular disease like corneal ulcer, mucopurulent conjunctivitis etc. -Traumatic patients with sub- conjunctival haemorrhage with visual loss with retinal involvement are excluded -Blood disorder having leukemia , purpura excluded -Post Covid-19 patients with present complications

Design outcomes

Primary

Measure	Time frame
Rasotanjan is effective in ArjunaTimepoint: 15 days	—

Secondary

Measure	Time frame
Kasisanjan is effective in ArjunaTimepoint: 15 days	—

Countries

India

Contacts

Public ContactVd Monish Manohar Rangate

Hon Shri Annasaheb Dange Ayurved Medical College and Post Graduate Research Centre Ashta

dr.monishrangate@gmail.com9923429223

Outcome results